发明名称 |
METHODS FOR TREATING CARDIAC ARREST OR PULMONARY HYPERTENSION AND COMPOSITIONS FOR USE THEREIN COMPRISING VASOACTIVE INTESTINAL POLYPEPTIDE AND CARDIAC DEVICE FOR ELECTRICAL AND CHEMICAL REGULATION AND METHODS OF USE |
摘要 |
A method and device for discharging an electrical defibrillation pulse or an electrical demand pacer pulse or delivering at least one pharmaceutical agent to treat conditions such as cardiac arrest, bradycardia, arrhythmia, cardiac standstill, PEA, EMD and other heart conditions are disclosed. The pharmaceutical agent can be delivered into the heart tissue, the heart cavity, or the peritoneal cavity. The pharmaceutical agent can also include analgesics such as morphine. Also included are pharmaceutical agents used to increase myocardial contractility or inhibit platelet aggregation and vasoactive intestinal polypeptide (VIP) and thyroid hormones such as T3 and T4 can be delivered. A method for the treatment of cardiac arrest or pulmonary hypertension patients by administering a therapeutically effective amount of vasoactive intestinal polypeptide is also encompassed by the invention.
|
申请公布号 |
WO0134088(A2) |
申请公布日期 |
2001.05.17 |
申请号 |
WO2000US31348 |
申请日期 |
2000.11.13 |
申请人 |
RUBIN, LEO;BERNSTEIN, DAVID |
发明人 |
RUBIN, LEO;BERNSTEIN, DAVID |
分类号 |
A61N1/39;A61B17/00;A61K31/137;A61K31/167;A61K31/46;A61K33/00;A61K38/22;A61M5/142;A61M25/00;A61N1/05;A61N1/362;A61P9/04;A61P9/10;A61P9/12;(IPC1-7):A61H/ |
主分类号 |
A61N1/39 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|